[ad_1]
Polaris Inc.’s stock fell Tuesday, after the power sports vehicles maker posted weaker-than-expected second-quarter earnings and slashed its full-year guidance.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...